Search for Clinical Trial Results
Fallopian Tube Diseases - 25 Studies Found
Status | Study |
Completed |
Study Name: Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer Condition:
|
Recruiting |
Study Name: Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab Condition:
|
Recruiting |
Study Name: A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condition:
|
Recruiting |
Study Name: A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer Condition:
|
Not yet recruiting |
Study Name: Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Condition:
|
Recruiting |
Study Name: Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients _MITO-23 Condition: Ovarian Neoplasms Date: 2016-08-26 Interventions:
|
Recruiting |
Study Name: A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers Condition:
|
Recruiting |
Study Name: LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer Condition:
|
Active, not recruiting |
Study Name: A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer Condition:
|
Recruiting |
Study Name: A Study of Long-Term Responders on Olaparib Condition:
|